APA (7th ed.) Citation

SD, D., S, Y., S, R., & JR, G. (2024). LC-ESI-MS/MS method validation for simultaneous quantification of FDA-approved anticancer agents futibatinib and binimetinib in rat plasma: Insights from preclinical pharmacokinetics. Biomedical chromatography : BMC, 38(11), e6005. https://doi.org/10.1002/bmc.6005

Chicago Style (17th ed.) Citation

SD, Dadge, Yadav S, Rathaur S, and Gayen JR. "LC-ESI-MS/MS Method Validation for Simultaneous Quantification of FDA-approved Anticancer Agents Futibatinib and Binimetinib in Rat Plasma: Insights from Preclinical Pharmacokinetics." Biomedical Chromatography : BMC 38, no. 11 (2024): e6005. https://doi.org/10.1002/bmc.6005.

MLA (9th ed.) Citation

SD, Dadge, et al. "LC-ESI-MS/MS Method Validation for Simultaneous Quantification of FDA-approved Anticancer Agents Futibatinib and Binimetinib in Rat Plasma: Insights from Preclinical Pharmacokinetics." Biomedical Chromatography : BMC, vol. 38, no. 11, 2024, p. e6005, https://doi.org/10.1002/bmc.6005.